Prevalence and psychopathological characteristics of depression in consecutive otorhinolaryngologic inpatients

BMC Ear, Nose and Throat Disorders

Maren Boecker³  Siegfried Gauggel³  Martin Westhofen¹  Eftychia Volz-Sidiropoulou³  Thomas Vehren³  Markus Wirtz⁴  Christine Norra²  Thomas Forkmann³ 

[1] Clinic for Otorhinolaryngology, University Hospital of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany;Dept. of Psychiatry and Psychotherapy, LWL-University-Clinic, Ruhr-University Bochum, Alexandrinenstr. 1-3, 44791 Bochum, Germany;Institute of Medical Psychology and Medical Sociology, University Hospital of RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany;Institute of Psychology, University of Education Freiburg, Kartäuserstr. 61b, 79117 Freiburg, Germany

关键词: otorhinolaryngology;    otolaryngologic inpatients;    depression;    pathopsychology;    prevalence;   

Others  :  862847
DOI  :  10.1186/1472-6815-11-7

 received in 2010-12-01, accepted in 2011-08-31,  发布年份 2011

【 摘 要 】

Background

High prevalence of depression has been reported in otorhinolaryngologic patients (ORL). However, studies using a semi-structured interview to determine the prevalence of depression in ORL are lacking. Therefore the present study sought to determine the depression prevalence in ORL applying a semi-structured diagnostic interview and to further characterize the pathopsychological and demographic characteristics of depression in these patients.

Methods

One-hundred inpatients of the otorhinolaryngologic department of a German university hospital participated voluntarily (age M = 38.8 years, SD = 13.9; 38.0% female). Depression was assessed using a clinical interview in which the International Diagnostic Checklist for depression (IDCL) was applied. Patients completed the Brief Symptom Inventory (BSI) which constitutes three composite scores and nine symptom scales and the Beck Depression Inventory (BDI). Multivariate analyses of variance, correlations and effect sizes were conducted.

Results

A prevalence of depression of 21.0% was determined, 38.0% of the depressed patients were female. Depressed patients showed higher scores on the BSI-scales "interpersonal sensitivity", "depression", "anxiety", "phobic anxiety" and "psychoticism" with medium effect sizes.

Conclusions

High prevalence of depression was found which is in accordance with results of prior studies. Depressed patients showed higher psychological distress as compared to non-depressed patients. The results call for carrying on in engaging in depression research and routine depression screening in ORL.

【 授权许可】

   
2011 Forkmann et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Waraich P, Goldner EM, Somers JM, Hsu L: Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004, 49:124-138.
• [2]Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
• [3]Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW: Depression and multiple sclerosis. Neurology 1996, 46:628-632.
• [4]Verdelho A, Henon H, Lebert F, Pasquier F, Leys D: Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study. Neurology 2004, 62:905-911.
• [5]Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
• [6]Bankier B, Januzzi JL, Littman AB: The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosom Med 2004, 66:645-650.
• [7]Bhattacharyya N, Wasan A: Do anxiety and depression confound symptom reporting and diagnostic accuracy in chronic rhinosinusitis? Ann Otol Rhinol Laryngol 2008, 117:18-23.
• [8]Wasan A, Fernandez E, Jamison RN, Bhattacharyya N: Association of anxiety and depression with reported disease severity in patients undergoing evaluation for chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2007, 116:491-497.
• [9]Mace J, Michael YL, Carlson NE, Litvack JR, Smith TL: Effects of depression on quality of life improvement after endoscopic sinus surgery. Laryngoscope 2008, 118:528-534.
• [10]Brandsted R, Sindwani R: Impact of depression on disease-specific symptoms and quality of life in patients with chronic rhinosinusitis. Am J Rhinol 2007, 21:50-54.
• [11]Chandra RK, Epstein VA, Fishman AJ: Prevalence of depression and antidepressant use in an otolaryngology patient population. Otolaryngol Head Neck Surg 2009, 141:136-138.
• [12]Hellgren J, Balder B, Palmqvist M, Löwhagen O, Tunsäter A, Karlsson G, Torén K: Quality of life in non-infectious rhinitis and asthma. Rhinology 2004, 42:183-188.
• [13]Bronheim H, Strain JJ, Biller HF: Psychiatric aspects of head and neck surgery. Part I: New surgical techniques and psychiatric consequences. Gen Hosp Psychiatry 1991, 13:165-176.
• [14]Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H, Uchitomi Y: Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000, 88:2817-2823.
• [15]Singer S, Herrmann E, Welzel C, Klemm E, Heim M, Schwarz R: Comorbid mental disorders in laryngectomees. Onkologie 2005, 28:631-636.
• [16]World Medical Association: Proposed revision of the Declaration of Helsinki. Bull Med Ethics 1999, 150:18-22.
• [17]Hiller W, Zaudiga M, Mombour W: ICD International Diagnostic Checklists for ICD-10 and DSM-IV. Göttingen: Hogrefe & Huber Pub; 1999.
• [18]World Health Organization: The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
• [19]Derogatis LR: The Symptom Checklist-90-revised. Minneapolis: NCS Assessments; 1992.
• [20]Derogatis LR: The Brief Symptom Inventory (BSI): Administration, scoring and procedures manual. 3rd edition. Mineapolis: National Computer System; 1993.
• [21]Beck AT, Steer RA: Beck Depression Inventory. San Antonio: The Psychological Corporation Inc.; 1987.
• [22]Forkmann T, Boecker M, Norra C, Eberle N, Kircher T, Schauerte P, Mischke K, Westhofen M, Gauggel S, Wirtz M: Development of an item bank for the assessment of depression in persons with mental illnesses and physical diseases using Rasch analysis. Rehabil Psychol 2009, 54:186-197.
• [23]Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. Orlando: Academic Press; 1985.
• [24]Cohen J: Statistical power for the behavioural science. 2nd edition. Hillsdale: Erlbaum; 1988.
• [25]Dunlap WP, Cortina JM, Vaslow JB, Burke MJ: Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods 1996, 1:170-177.
• [26]Wittchen HU, Jacobi F: Size and burden of mental disorders in Europe- a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005, 15:357-376.
• [27]Abramowitz JS: Treatment of obsessive-compulsive disorder in patients who have comorbid major depression. J Clin Psychol 2004, 60:1133-1141.
• [28]DeVane CL, Chiao E, Franklin M, Kruep EJ: Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. Am J Manag Care 2005, 11:S344-S353.
• [29]Rudisch B, Nemeroff CB: Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003, 54:227-240.
• [30]Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54:376-387.
• [31]Stunkard AJ, Faith MS, Allison KC: Depression and obesity. Biol Psychiatry 2003, 54:330-337.
• [32]Raison CL, Miller AH: Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003, 54:283-294.
• [33]Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM: Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry 2003, 54:307-316.
• [34]Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA: Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
• [35]Norra C, Skobel EC, Arndt M, Schauerte P: High impact of depression in heart failure: early diagnosis and treatment options. Int J Cardiol 2008, 125:220-231.
• [36]Forkmann T, Boecker M, Wirtz M, Eberle N, Westhofen M, Schauerte P, Mischke K, Kircher T, Gauggel S, Norra C: Development and validation of the Rasch-based depression screening (DESC) using Rasch analysis and structural equation modelling. J Behav Ther Exp Psychiatry 2009, 40:468-78.